1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Demographic and clinical data for control and patient groups^{^a}
Control PD MSA-P PSP P Value
No. of subjects 36 35 16 19 
Female/male 13:23 12:23 8:8 4:15 .356^{^b}
Age (yr) 70.0 ± 7.5 70.3 ± 7.9 68.0 ± 7.5 74.9 ± 8.7 .057^{^c}
Disease duration (yr) – 3.4 ± 3.6 3.9 ± 3.3 3.2 ± 2.8 .812^{^c}
MoCA 25 ± 2.3 22.8 ± 4.5 23.9 ± 2.7 20.1 ± 4.9 .002,^{^d} .120^{^e}
UPDRS III 4.6 ± 3.6 36.6 ± 27.3 51.5 ± 20.0 46.6 ± 23.4 <.0001,^{^d} .145^{^e}
↵a Data are sums or mean ± SD.
↵b Group difference in sex was compared among all 4 groups using the χ² test.
↵c Group differences in age and disease duration were compared using 1-way ANOVA.
↵d Group differences in MoCA and UPDRS-III were compared among all 4 groups using ANCOVA with adjustments for age and sex.
↵e Group differences in MoCA and UPDRS-III were compared among the 3 patient groups, using ANCOVA with adjustments for age and sex.